Warby Parker Inc. (WRBY) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $2.89B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | US | CEO | Neil Harris Blumenthal |
| IPO Date | 2021-09-29 | CAGR | 15.33% |
| Employees | 4,036 | Website | www.warbyparker.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 1.26% | Total Yield | 1.26% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $3.35B | P/E | 73.59 | Forward P/E | 39.59 | PEG | — |
| P/S | 0.93 | P/B | 2.2 | P/CF | 9.03 | P/FCF | 39.2 |
| Sales | $911.61M | Sales 1Y | 10.99% | Sales 3Y | 43.94% | Sales 5Y | 87.01% |
| EPS | $0.32 | EPS 1Y | -186.57% | EPS 3Y | -110.66% | EPS 5Y | -101.53% |
| Sales QoQ | -2.86% | EPS QoQ | 33.33% | Sales QoQ Avg | 2.62% | EPS QoQ Avg | -189.73% |
| Gross Margin | 54.68% | Operating Margin | 0.17% | Profit Margin | 0.85% | ROCE | 0.25% |
| ROA | 1% | ROE | 2% | Altman Z Score | 4.95 | Piotroski Score | 6 |
| Current Ratio | 2.27 | Quick Ratio | 2.01 | Cash Ratio | 1.79 | Op. CF Ratio | 0.18 |
| Debt/Equity | 0.64 | Debt/Assets | 0.32 | Lt Debt/Equity | 0.55 | Lt Debt/Cap. | 0.35 |
| Intrst Cov. | — | Inventory Turnover | 9.81 | Asset Turnover | 1.18 | Receivables Turnover | 438.27 |
| Enterprise Value | $3.35B | P/E Ratio | 73.59 |
| Forward P/E | 39.59 | PEG Ratio | — |
| P/S Ratio | 0.93 | P/B Ratio | 2.2 |
| P/CF Ratio | 9.03 | P/FCF Ratio | 39.2 |
| EPS | $0.32 | EPS Growth 1Y | -186.57% |
| EPS Growth 3Y | -110.66% | EPS Growth 5Y | -101.53% |
| Revenue Growth 1Y | 10.99% | Gross Margin | 0.55% |
| Operating Margin | 0% | Profit Margin | 0.01% |
| ROE | 0.02% | ROA | 0.01% |
| ROCE | 0% | Current Ratio | 2.27 |
| Quick Ratio | 2.01 | Cash Ratio | 1.79 |
| Debt/Equity | 0.64 | Interest Coverage | — |
| Altman Z Score | 4.95 | Piotroski Score | 6 |
Warby Parker Inc. (WRBY) valuation & financials
Warby Parker Inc. (WRBY) has a market capitalization of $2.89B and trades at a price-to-earnings ratio of 73.6. It operates in the Healthcare sector (Medical - Instruments & Supplies).
Warby Parker Inc.'s revenue grew +11.0% over the last year.
Warby Parker Inc.'s next earnings report is scheduled for November 5, 2026 before market open; analysts estimate EPS of $0.09. Check the earnings calendar to see all companies reporting this week.
Warby Parker Inc. (WRBY) — frequently asked questions
When does Warby Parker Inc. (WRBY) report earnings next?
Warby Parker Inc. is expected to report earnings on November 5, 2026 before market open. Analysts estimate EPS of $0.09.
What is Warby Parker Inc.'s market cap?
Warby Parker Inc. (WRBY) has a market capitalization of $2.89B.
What is WRBY's P/E ratio?
Warby Parker Inc. trades at a price-to-earnings ratio of 73.6, with trailing twelve-month EPS of $0.32.
How fast is Warby Parker Inc. growing?
Warby Parker Inc.'s revenue grew +11.0% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)